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Summary statement 16 
The EMT is a highly conserved process, involving similar levels of regulation in 17 
both neural crest and cancer cells.  Our work shows an epigenetic-miRNA-gene 18 
regulatory circuit, conserved in cancer, which controls the timing of neural crest 19 
EMT as well. 20 
  21 
Abstract 22 
miR-203 is a tumor-suppressor microRNA with known functions in cancer 23 
metastasis.  Here, we explore its normal developmental role in the context of 24 
neural crest development. As neural crest cells undergo an epithelial-to-25 
mesenchymal transition to emigrate from the neural tube, miR-203 displays a 26 
reciprocal expression pattern with key regulators of neural crest delamination, 27 
Phf12 and Snail2, and interacts with their 3’UTRs. Ectopic maintenance of miR-28 
203 inhibits neural crest migration, whereas its functional inhibition using a 29 
“sponge” vector promotes premature neural crest delamination. Bisulfite 30 
sequencing further shows that epigenetic repression of miR-203 is mediated by 31 
the de novo DNA methyltransferase DNMT3B, whose recruitment to regulatory 32 
regions on the miR-203 locus is directed by SNAIL2 in a negative feedback 33 
loop. These findings reveal an important role for miR-203 in an epigenetic-34 
microRNA regulatory network that influences the timing of neural crest 35 
delamination.  36 
 37 
 38 
 39 
  40 
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Introduction 41 
Neural crest cells (NCC) are a transient embryonic cell population that arise in 42 
the neuroectoderm, then migrate to the periphery where they contribute to 43 
diverse derivatives including craniofacial bone and cartilage, neurons and glia of 44 
the peripheral nervous system, pigment cells, and portions of the cardiovascular 45 
system (Crane and Trainor, 2006). NCC emigrate from the forming central 46 
nervous system by undergoing an epithelial-mesenchymal transition (EMT), 47 
similar to that observed during initiation of tumor metastasis (Kerosuo and 48 
Bronner-Fraser, 2012). An evolutionarily conserved gene regulatory network 49 
(GRN) regulates NCC EMT and depends upon the coordinated action of 50 
transcription factors including Snail1/2, Zeb2 (Sip1), and FoxD3 (Simoes-Costa 51 
and Bronner, 2015). In addition to transcriptional regulators mediating neural 52 
crest EMT, epigenetic mechanisms including DNA methylation (Hu et al., 2012, 53 
Hu et al., 2014) and histone modifications (Strobl-Mazzulla and Bronner, 2012, 54 
Strobl-Mazzulla et al., 2010) are also at play. In particular, a repressor complex, 55 
comprised of SNAIL2 and the epigenetic reader PHF12 represses cadherin 6b 56 
(Cad6b) (Strobl-Mazzulla and Bronner, 2012), whose down-regulation is 57 
required for initiation of neural crest delamination from the neural tube. These 58 
results demonstrate an additional level of fine tuning and important role for 59 
epigenetic regulators during neural crest EMT, raising the intriguing possibility 60 
that other yet to be identified factors may be involved.   61 
In recent years, microRNAs (miRNAs) have been shown to be key regulators of 62 
EMT in several tumor cells (Diaz-Lopez et al., 2014, Ding, 2014, Xia and Hui, 63 
2012). MicroRNAs are ∼22-nucleotides single-stranded RNAs that negatively 64 
regulate gene expression post-transcriptionally (Kloosterman and Plasterk, 65 
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2006) by inhibiting translation and/or causing degradation by binding to 66 
complementary sequences located at the 3’-untranslated region (3’-UTR) of 67 
target mRNAs. Approximately 50% of miRNAs genes are embedded or 68 
associated with CpGs islands, and their expression is most often regulated by 69 
methylation of cytosines therein (Weber et al., 2007). In several tumor cells, it 70 
has been shown that hypermethylation of anti-tumoral miRNAs leads to 71 
initiation of EMT (Ahmad et al., 2014, Kiesslich et al., 2013, Lujambio et al., 72 
2008, Wang et al., 2012, Bonnomet et al., 2010, Diaz-Lopez et al., 2014, Ding, 73 
2014, Nelson and Weiss, 2008, Xia and Hui, 2012). The commonalities 74 
between the migration of cancer cells and embryonic neural crest cells (Mayor 75 
and Theveneau, 2013, Scarpa and Mayor, 2016, Friedl and Gilmour, 2009) 76 
suggest the intriguing possibility that similar epigenetic-microRNA to those 77 
functioning in metastasis may be involved in NCC development. As case in 78 
point, we describe in avian embryos that the epigenetic repression of miR-203, 79 
directed by SNAIL2 enables upregulation of two of its direct targets, Phf12 and 80 
Snail2, necessary for the delamination of the neural crest from the neural tube. 81 
These findings support the idea that a single microRNA, regulating key genes of 82 
the EMT process, may “throw” a precise switch mediating an epithelial to a 83 
mesenchymal state of neural crest cells.   84 
Results  85 
miR-203 expression is reduced at the time of NCC delamination   86 
Given that Phf12 and Snail2 are involved in regulation of NCC EMT (Strobl-87 
Mazzulla and Bronner, 2012), we performed an in silico and literature analysis 88 
to investigate miRNAs that might regulate these transcription factors. 89 
Interestingly, we found 9 and 7 families, respectively, of miRNAs in the 3’UTRs 90 
(which was not peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission. 
The copyright holder for this preprint. http://dx.doi.org/10.1101/392142doi: bioRxiv preprint first posted online Aug. 14, 2018; 
5 
 
of Phf12 and Snail2 with sites conserved across vertebrates (Table S1). Based 91 
on its their reported functionality, demonstrated target genes and expression 92 
pattern during chick development (Darnell et al., 2006), we further focused on 93 
miR-203 for in depth analysis. Importantly, miR-203 has been described to act 94 
as tumor suppressor (Benaich et al., 2014, Miao et al., 2014, Zhu et al., 2013b), 95 
that directly regulates Snail2 expression (Gao et al., 2017, Shi et al., 2015, 96 
Zhang et al., 2015, Xiao et al., 2017), whose epigenetic repression causes 97 
metastasis in several tumor cells including NCC-derived melanoma (Boldrup et 98 
al., 2012, Boll et al., 2013, Chen et al., 2012, Chiang et al., 2011, Ding et al., 99 
2013, Furuta et al., 2010, Huang et al., 2014, Ju et al., 2014, Moes et al., 2012, 100 
Zhang et al., 2014, Zhao et al., 2013, Bu and Yang, 2014, Lohcharoenkal et al., 101 
2018). Moreover, the mature miR-203 sequence is highly conserved throughout 102 
vertebrates including the basal lamprey (Fig. 1B), suggesting an ancient and 103 
conserved function. 104 
As a first step in analyzing its possible function during NCC development, we 105 
examined the expression pattern of miR-203 transcripts by in situ hybridization 106 
(ISH) in early chick embryos. By using LNA-DIG labelled probes, we found that 107 
mature miR-203 expression begins during gastrulation by stage 4 (Fig. S1A). 108 
During neurulation at the 1-4 somite stage (ss), miR-203 is consistently 109 
expressed in the forming neural tube (Fig. 1A). Interestingly, we observed a 110 
clear reduction by the 5 to 8ss in the miR-203 expression in the cranial neural 111 
tube, corresponding to the initiation of neural crest emigration. Analyses by 112 
stem-loop RT-qPCR confirmed that mature miR-203 expression is reduced from 113 
5 to 6ss, coincident with the increase of Snail2 and Phf12 expression at the time 114 
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of NCC delamination (Fig. 1C). These results are consistent with the intriguing 115 
possibility that miR-203 has an important role in neural crest EMT.  116 
 117 
Figure 1: miR-203 expression is reduced at the time of NCC delamination. (A) Whole-118 
mount in situ hybridization (ISH) using LNA-DIG labelled probes reveals a specific expression of 119 
the mature miR-203 on the neural tube which is reduced from 5 somite stage (ss) to 9ss. (B) 120 
Conservation analysis of miR-203 in vertebrates. Gga (Gallus gallus), xtr (Xenopus tropicalis), 121 
dre (Danio rerio), ola (Oryzias latipes), hsa (Homo sapiens), ptr (Pan troflodytes), mmu (Mus 122 
musculus), pma (Petromyzon marinus). (C) RT-qPCR analyses show reducing miR-203 123 
expression from 5 to 6ss in an opposite manner than the observed increase on Snail2 and 124 
Phf12 expression at the beginning of NCC delamination. 125 
 126 
 127 
 128 
 129 
miR-203 locus is highly methylated on pre-migratory NCC  130 
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In several metastatic tumor cells, the miR-203 locus is epigenetically silenced 131 
by DNA methylation (Chim et al., 2011a, Chim et al., 2011b, Diao et al., 2014, 132 
Furuta et al., 2010, Huang et al., 2014, Taube et al., 2013, Zhang et al., 2013, 133 
Zhang et al., 2011). Interestingly, we found by in silico analysis that the miR-203 134 
locus is embedded in a CpG island (Fig. 2A). On this basis, we selected two 135 
genomic regions, one at the putative proximal promoter (region 1) and the other 136 
at the beginning of the pri-miR-203 (region 2), to analyze the DNA methylation 137 
abundance on pre-migratory (PM-NCC) or migratory (M-NCC) neural crest cells 138 
and the ventral neural tube (NT). By using bisulfite conversion, we observed 139 
high enrichment on methylated CpGs in region 2, but not on region 1, in the 140 
PM-NCC compared with the low abundance detected on the M-NCC and NT 141 
(Fig. 2B-C). These significant differences are clearly evident when comparing 142 
the total percentage of methylated CpGs (Fig. 2D-E) from the different samples. 143 
We identified that 18.4% and 28.9% of the CpGs are methylated on region 1 144 
and 2 on PM-NCC, compared with 9.5% and 6.1% on the NT, and 5.3% and 7% 145 
detected on the M-NCC, respectively. These results suggest that the decreased 146 
expression of miR-203 in pre-migratory NC may be the consequence of 147 
hypermethylation of its locus. 148 
 149 
DNMT3B and SNAIL2 are required for miR-203 methylation 150 
De novo DNA methyltransferases DNMT3A and 3B are both involved in neural 151 
crest development (Hu et al., 2012). To examine the possibility that DNA 152 
methylation may be involved in regulating miR-203 expression, we examined 153 
the effects of loss of DNMT3A and 3B on miR-203 expression. To this end, we 154 
performed bisulfite sequencing after loss of function experiments with previously 155 
characterized fluorescein-tagged morpholino oligonucleotides, DNMT3A-MO 156 
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and DNMT3B-MO (Hu et al., 2012, Hu et al., 2014). After unilateral injection and 157 
electroporation, dorsal neural tubes from 6ss embryos were dissected and 158 
bisulfite converted to analyze the methylation abundance on region 2 of miR-159 
203 locus (Fig. 2A). The results show that loss of function of either of the two 160 
DNMTs consistently decreases the abundance of methylated CpGs in the 161 
region 2 (Fig. 2F). However, depletion of DNMT3B, but not DNMT3A, resulted 162 
in significant differences in methylation of miR-203. 163 
Transcription factors specifically bind to target DNAs to recruit and guide DNA 164 
methyltransferases to specific genomic sites (Siegfried and Simon, 2010). 165 
During tumor metastasis, SNAIL2 binds to the miR-203 promoter to inhibit its 166 
transcription (Ding et al., 2013), though the mechanism underlying this 167 
repression is unknown. Our bioinformatic analysis reveal several SNAIL2-168 
binding sites ~1kb upstream of the pre-miR-203 (Fig. 2A, Table S2), two of 169 
which have a high binding score (>9) accordingly to JASPAR 2018 170 
(http://jaspar.genereg.net/). To test the effects of SNAIL2 loss of function, we 171 
electroporated a previously characterized Snail2 morpholino (Snail2-MO) 172 
(Taneyhill et al., 2007) unilaterally and dissected half dorsal neural tubes from 173 
6ss embryos for analysis of miR-203 expression and DNA methylation. 174 
Interestingly, the results show that Snail2 knockdown causes a significant 175 
upregulation of miR-203 expression (Fig. 2G). Consistent with this finding, we 176 
found a significant reduction in the abundance of methylated CpGs in region 2 177 
of the miR-203 locus (Fig. 2H). These results suggest that SNAIL2 is involved in 178 
the epigenetic repression of miR-203 in the premigratory neural crest.   179 
(which was not peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission. 
The copyright holder for this preprint. http://dx.doi.org/10.1101/392142doi: bioRxiv preprint first posted online Aug. 14, 2018; 
9 
 
 180 
Figure 2: SNAIL2 and DNMT3B are required for DNA methylation on miR-203 locus on 181 
premigratory NCC. (A) miR-203 genomic context. The CpG island content (green bar) for miR-182 
203 gene was identified using the UCSC genome browser (https://genome.ucsc.edu/) and 183 
Ensembl (http://www.ensembl.org/). The putative transcriptional start sites (TSS) were obtained 184 
using Eponine (https://www.sanger.ac.uk/science/tools/eponine). The putative binding sites for 185 
SNAIL2 were mapped using JASPAR 2018 (http://jaspar.genereg.net/). We also show the two 186 
regions used in our bisulfite sequencing and the pre-miR-203 accordingly to the miRbase 187 
(http://www.mirbase.org/). Bisulfite sequencing profiles of CpGs methylation on the region 1 (B) 188 
and region 2 (C) were analyzed on pre-migratory NCC (PM-NCC), migratory NCC (M-NC), and 189 
ventral neural tube (NT). Percentage of each methylated CpG sites are shown with filled (100% 190 
methylated) and open (0% methylated) circles. Bar graph represent the total percentages of 191 
methylated CpGs on the different regions for the three analyzed samples on the region 1 (D) 192 
and the region 2 (E). We evidenced in PM-NCC a higher percentage of methylated CpGs 193 
compared with the other samples. Number in brackets indicated the analyzed sequences. 194 
Asterisk (*) indicate significant differences by ANOVA. (F) Morpholino-mediated loss of 195 
DNMT3A (DNMT3A-MO) and DNMT3B (DNMT3B-MO) function results in a reduction of 196 
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methylated CpGs on the injected side (IS) compared with the uninjected side (UIS) of the same 197 
group of embryos. Morpholino-mediated loss of SNAIL2 (SNAIL2-MO) function maintains an 198 
elevated level of miR-203 expression (G) and reduced CpGs methylation on the region 2 (H) on 199 
the IS compared with the UIS of the same group of embryos. Asterisk (*) indicate significant 200 
differences by Student's t-test. 201 
 202 
Overexpression of miR-203 causes loss of migrating NCC  203 
Since miR-203 expression is epigenetically repressed at the initiation of their 204 
migration, we asked whether maintenance of miR-203 expression would 205 
prevent neural crest delamination. To this end, we designed an overexpression 206 
vector in which we cloned the pre-miR-203 sequence, plus a few hundred base 207 
pair arms for correct processing, under the control of CAG promoter (pCAG-208 
203) (Fig. 3A). Overexpression of miR-203 in pCAG-miR-203 electroporated 209 
embryos was confirmed by LNA-ISH (Fig. S2B). To demonstrate that the pCAG-210 
miR-203 expresses a functional miR-203, we first used a two-colored sensor 211 
vector (Cao et al., 2007) comprised of a nuclear-localized destabilized EGFP 212 
with a half-life of 4 hours (d4EGFPN), driven by a CAG promoter, followed by a 213 
3’UTR containing two copies of a bulged complementary sequence for miR-203. 214 
In addition, the vector contains a nuclear-localized monomeric red fluorescent 215 
protein (mRFPN) driven by another CAG promoter that serves as an 216 
electroporation control (see scheme of pSdmiR-203 in figure S2C). Together 217 
with the dual sensor pSdmiR-203, we co-electroporated either control empty 218 
vector (left) or the vector expressing miR-203 (right) onto each side of the 219 
embryo (Fig. S2D). The results show that on the control side, most of the 220 
electroporated cells appeared yellow, due to expression of d4EGFPN and 221 
mRFPN. However, on the experimental side, overexpression of miR-203 causes 222 
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a strong reduction of d4EGFPN and the cells only express mRFPN (Fig. S2E). 223 
These results confirm the functionality of our miR-203 expression construct. 224 
Gain-of-function experiments were conducted by electroporating the miR-203 225 
vector on one side of the embryo (Fig. S2A). The results show that miR-203 226 
overexpression causes a drastic reduction in the numbers of migratory neural 227 
crest cells identified by Sox10 expression (Fig. 3B). By categorizing embryos 228 
according to their phenotype (normal or reduced migratory NCC), we observed 229 
a significant increase in the number of embryos with a reduced number of 230 
migratory NCC on pCAG-203 electroporated side compared with control 231 
embryos electroporated with an empty vector (pCAG) (Fig. 3C). To rule out the 232 
possibility that this may be secondary to a specification defect, we analyzed the 233 
expression of early neural crest specifier genes by immunohistochemistry at 234 
pre-migratory stages. Interestingly, our results demonstrate that overexpression 235 
of miR-203 does not affect expression of FOXD3, one of earliest neural crest 236 
specification markers (Fig. 3D), suggesting that specification occurs normally. In 237 
contrast, there was a clear reduction in SNAIL2, demonstrating reciprocal 238 
repression.  Taken together, our results highlight the role of miR-203 in NCC 239 
delamination, likely by affecting EMT inducers like SNAIL2.  240 
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 241 
Figure 3: miR-203 overexpression prevents NCC delamination without affecting 242 
specification. (A) Scheme of pCAG-203 vector to overexpress miR-203. (B) In situ 243 
hybridization for Sox10 showed inhibition of NCC migration in the pCAG-203 injected side, in 244 
comparison with the uninjected side of the same embryos and with embryos injected with an 245 
empty pCAG vector. (C) Quantitation of the embryos according to their phenotypes (normal 246 
migration versus inhibition of migration) was analyzed. Numbers in the graphs represent the 247 
numbers of analyzed embryos. ****P < 0,0001 by contingency table followed by X2 test. (D) 248 
Immunohistochemistry analyzes on miR-203 overexpressing embryos evidenced a reduced 249 
expression of SNAIL2 but does not affect the expression of the early NCC specifier FOXD3. 250 
 251 
Loss of miR-203 function causes premature NCC delamination   252 
Given that miR-203 is epigenetically repressed in pre-migratory NCC and 253 
overexpression of miR-203 causes defect in their delamination, we next asked if 254 
early loss of miR-203 function would result in premature neural crest 255 
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delamination. To test this possibility we adapted a protocol (Kluiver et al., 2012) 256 
to generate a “sponge” vector containing repeated miR-203 antisense 257 
sequences (pSmiR-203) to sequester endogenous miR-203 (Fig. 4A). A sponge 258 
vector containing a scrambled sequence (pSmiR-scramble) was designed as a 259 
control. As predicted, electroporation of pSmiR-203 resulted in premature NCC 260 
migration, when compared with the contralateral uninjected side, analyzed by 261 
immunohistochemistry for SNAIL2 and FOXD3, or by ISH for Sox10 (Fig. 4B). 262 
Importantly, no difference in timing of delamination was observed after 263 
electroporation of the pSmiR-scramble. By categorizing embryos according to 264 
their phenotype, premature versus normal migration, we observed a significant 265 
difference in percentage of embryos exhibiting premature NCC migration in 266 
pSmiR-203 electroporated embryos (Fig. 4C). Notably, reduction of miR-203 267 
function altered not only initiation of NCC delamination, but also shortened the 268 
overall length of time during which delamination occurred (Fig. 4D-D’). This is 269 
based on the observation that on the side injected with pSmiR-203, all the 270 
Sox10+ NCCs have completed their delamination, compared with the 271 
contralateral side where many premigratory neural crest cells still persist on the 272 
dorsal neural tube. These results clearly confirm that miR-203 controls the 273 
temporal regulation of NCC delamination. 274 
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 275 
Figure 4: miR-203 sponge vector causes premature NCC delamination. (A) Scheme of 276 
pSmiR-203 sponge vector having a bulged miR-203 antisense sequences downstream of the 277 
EGFP reporter. (B) Electroporated embryos with pSmiR-203 causes premature migration of 278 
NCC evidenced by in situ hybridization for Sox10 and immunohistochemistry for SNAIL2 and 279 
FOXD3, and compared with the uninjected side of the same embryos or injected with pSmiR-280 
scramble vector. Arrowhead indicated premature migratory neural crest cells. (C) Quantitation of 281 
pSmiR-203 or pSmiR-scramble treated embryos according to the observation of premature 282 
NCC migration. Numbers in the graph represent the analyzed embryos. ****P<0,0001 by 283 
contingency table followed by X2 test. (D-D’) Neural crest cells from the sponge injected site 284 
complete their delamination in advance compare with the uninjected site where many Sox10 285 
expressing cells are still on the neural tube (see black arrowhead). 286 
 287 
miR-203 targets the 3’UTRs of Snail2 and Phf12 288 
To test whether Snail2 and Phf12 genes are direct targets of miR-203, we 289 
designed two-colored sensor vectors in which we cloned, downstream of the 290 
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pCAG and d4EGFPN, the 3’UTRs containing the wild (pUTR-Snail2/Phf12) or 291 
mutated (pUTR-mutSnail2/Phf12) miR-203 binding sites (Fig. 5A). Co-292 
electroporation of these vectors (Fig. 5B) demonstrated that overexpression of 293 
miR-203 specifically inhibited d4EGFPN expression when it was fused to the 294 
3’UTRs of Snail2 and Phf12 but was uniformly distributed when miR-203 295 
binding sites were mutated (Fig. 5C-D). These results confirm that Snail2 and 296 
Phf12 are endogenous targets of the same microRNA, miR-203. 297 
 298 
Figure 5: Snail2 and Phf12 3’UTRs are direct targets of miR-203. (A) Scheme of dual 299 
colored sensor vector containing wild or mutated (mt) 3’UTRs from Snail2 (pUTR-Snail2) and 300 
Phf12 (pUTR-Phf12). pCAG, Chick β-actin promoter; d4EGFPN nuclear-localized destabilized 301 
EGFP with a half-life of 4 h; mRFPN, nuclear-localized monomeric red fluorescent protein. (B) 302 
Diagram of electroporation assays for 3’UTR-sensor experiments.   Electroporation of sensor 303 
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vector containing the 3’UTRs for (C) Snail2 (pUTR-Snail2) or (D) Phf12 (pUTR-Phf12) together 304 
with miR-203 overexpressing vector (pCAG-203) causes a consistent reduction on the 305 
d4EGFPN expression (right side) compared with the control side (left side). Mutation of miR-306 
203-binding sites in the 3’UTRs of Snail2 (pUTR-mtSnail2) or Phf12 (pUTR-mtPhf12) caused 307 
that most of the electroporated cells were yellow, expressing both d4EGFPN and mRFPN, even 308 
when miR-203 is overexpressed (right side).  309 
 310 
Discussion 311 
There is accumulating evidence for the importance of microRNAs in normal 312 
development as well as in several diseases, including tumor metastasis. Our 313 
study highlights the key role of a single microRNA, miR-203, in regulating the 314 
timing to initiation of the EMT program in neural crest cells. The results show 315 
that repression of miR-203 occurs via high levels of DNA methylation of the 316 
miR-203 locus by the DNMT3B, whose specific activity is directed by SNAIL2. 317 
In this scenario, repression of miR-203 is directed by SNAIL2 in a feedback-318 
loop that enables expression of two direct targets of miR-203, Phf12 and Snail2, 319 
which in turn are necessary for neural crest delamination. Finally, miR-203 gain- 320 
and loss-of-function cause reduction or premature NCC delamination, 321 
respectively. Taken together, the results reveal for the first time an epigenetic-322 
miRNA-gene regulatory circuit that controls the timing of neural crest 323 
delamination (Fig. 6A). These findings support the idea that a single microRNA 324 
may “throw the switch” from an epithelial to a mesenchymal state in the neural 325 
crest and thus stabilize the core gene regulatory networks in these two states. 326 
There is increasing evidence to suggest that miRNAs often act as fine-tuning 327 
regulators rather than as primary gene regulators (Hornstein and Shomron, 328 
2006). Accordingly, we postulate that miR-203 may act by shifting the levels of 329 
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SNAIL2 and PHF12 to prevent premature NCC delamination. A similar 330 
epigenetic-miRNA control of the core transcription factors necessary for EMT 331 
(EMT-TFs) has been also described in cancer cells (Wright et al., 2010, Guttilla 332 
et al., 2012, Xia and Hui, 2012, Kiesslich et al., 2013, Ding, 2014). Interestingly, 333 
some miRNAs and EMT-TFs form a tightly interconnected feedback loop that 334 
controls epithelial cell plasticity (Moes et al., 2012, Ding, 2014, Wellner et al., 335 
2009), similar to our observation that SNAIL2 directs the epigenetic repression 336 
of miR-203. These feedback-loops provide self-reinforcing signals and 337 
robustness to maintain the epithelial or mesenchymal cell state in response to 338 
different environmental cues. miR-203 is highly conserved from lamprey to 339 
human and appears to be an evolutionary novelty in vertebrates (Heimberg et 340 
al., 2010).  Our data demonstrate that miR-203 is a key regulator of NCC 341 
delamination by a reversible epigenetic-miRNAs. Given that the EMT program 342 
is a highly conserved process, involving similar transcription factors in both 343 
embryonic and cancer cells, these finding open new avenues for understanding 344 
normal and pathological development, as well as tumor metastasis. 345 
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 346 
Figure 6: Hypothetical model. Our results show that during NCC specification, miR-203 is 347 
highly expressed and preventing the initial accumulation of SNAIL2 and PHF12. Previous to 348 
NCC delamination, the accumulation of SNAIL2 causes the epigenetic silencing, mediated by 349 
DNMT3B, of miR-203. Then, the lack of miR-203 allows a rapid upregulation of both Snail2 and 350 
phd12 at the same time, which are necessaries for Cad6b repression at the beginning of the 351 
NCC epithelial-to-mesenchymal transition. 352 
 353 
Materials and methods  354 
RNA preparation and RT-qPCR 355 
RNA was prepared from individual embryos (n=6) using the isolation kit 356 
RNAqueous-Micro (Ambion) following the manufacturer’s instruction. The RNA 357 
was treated with amplification grade DNaseI (Invitrogen) and then reversed 358 
transcribed to cDNA with a reverse transcription kit (SuperScript II; Invitrogen) 359 
using stem-loop-miRNA-specifics (Chen et al., 2005) primers and random 360 
hexamers. QPCRs were performed using a 96-well plate qPCR machine 361 
(Stratagen) with SYBR green with ROX (Roche). Normalization controls genes 362 
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for qPCR were: for miR-203, miR-16 (Lardizabal et al., 2012) and for Snail2 and 363 
Phf12, Hprt1 (Simoes-Costa and Bronner, 2016). For a complete list of primer 364 
see table S3. 365 
 366 
Bisulfite sequencing 367 
Samples were obtained by dissecting of 9 embryos at stage 6ss, for 368 
premigratory NCC (PM-NCC), dorsal neural tube, and ventral neural tube (NT). 369 
In addition, we dissected 13 embryos at stage 11-13ss to obtain the migratory 370 
NCC (M-NCC). For the morpholino-mediated loss of DNMT3A, DNMT3B and 371 
SNAIL2 experiment, eight dorsal neural tubes from the injected and uninjected 372 
sides were dissected. For a complete list of morpholinos see table S3. All the 373 
tissues were lysed and bisulfite-converted with the EpiTect Plus Bisulfite 374 
Conversion Kit (Qiagen) following the manufacturer’s instructions. The 375 
regulatory regions of miR-203 were amplified by using two sets of nested 376 
primers (see table S3) from the bisulfite-converted DNA. The obtained products 377 
were gel-purified and cloned into the pGEM-T Easy Vector (Promega). 378 
Individual clones were sequenced and analyzed. 379 
 380 
Electroporation 381 
Chicken embryos were electroporated at stage 4-5 using previously described 382 
techniques (Sauka‐Spengler and Barembaum, 2008). The vectors and 383 
morpholinos were injected by air pressure using a glass micropipette and 384 
platinum electrodes were placed vertically across the chick embryos and 385 
electroporated with five pulses of 5.5 V for 50 ms at 100 ms intervals. Embryos 386 
were cultured in 0.5 ml albumen in tissue-culture dishes until the desired 387 
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stages. Embryos were then removed and fixed in 4% PFA and used for 388 
immunohistochemistry or in situ hybridization.  389 
 390 
In situ hybridization 391 
Whole-mount chick in situ hybridization for mRNAs and for microRNA was 392 
performed as described previously (Acloque et al., 2008, Darnell et al., 2006). 393 
LNA probe for miR-203 used in the assay were obtained from Exiqon and DIG-394 
labelled by using the DIG oligonucleotide 3’ end labeling kit (Roche). After ISH, 395 
some embryos were fixed in 4% PFA in PBS, washed, embedded in gelatin, 396 
and cryostat sectioned at a thickness of 14–16 µm. They were photographed 397 
using the NIS-Elements Advanced Research software (Nikon) with an Eclipse 398 
E600 microscope (Nikon) and processed using Photoshop CS3 (Adobe). 399 
 400 
Immunohistochemistry 401 
Whole-mount chick immunohistochemistry was performed as described 402 
previously (Taneyhill et al., 2007). Briefly, embryos were fixed for 15 min in 4% 403 
PFA and then permeabilized and blocked in TBS (500 mM Tris-HCl, pH 7.4, 1.5 404 
M NaCl, and 10 mM CaCl2) containing 0.1% Triton X-100 (TBS-T) and 5% FBS 405 
for 60 min at room temperature. Primary antibodies were diluted in TBS-T/FBS 406 
and incubated overnight at 4°C. Primary antibodies used were mouse anti-407 
Snail2 (1:100), (1:100; supplied by the Developmental Studies Hybridoma 408 
Bank), and rabbit anti-FoxD3 (1:300; gift of P. Labosky, Vanderbilt University 409 
Medical Center, Nashville, TN). Secondary antibodies used were goat anti-410 
mouse and anti-rabbit Alexa Fluor 594 (1:500; all obtained from Molecular 411 
Probes) diluted in TBS-T/FBS and incubated for 45 min at room temperature. 412 
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All washes were performed in TBS-T at room temperature. Some embryos were 413 
subsequently embedded in gelatin, cryostat sectioned at 12-16μm, 414 
photographed using the NIS-Elements Advanced Research software (Nikon) 415 
with an Eclipse E600 microscope (Nikon) and processed using Photoshop CS3 416 
(Adobe). 417 
 418 
MicroRNA sponge generation 419 
Oligos designed to generate miR-203 sponge were ordered phosphorylated and 420 
PAGE purified at a 100 nmol scale (see table S2) and dissolved to 50 mM in 421 
STE buffer (100 mM NaCl, 10 mM Tris/HCL, 1 mM EDTA, pH 8.0). Sense and 422 
antisense oligos were mixed at a 1:1 ratio and annealed by incubation at 100°C 423 
for 10 minutes followed by slow cooling. The “sponge” vector was generated 424 
following previously described protocols (Kluiver et al., 2012).  425 
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Supplemental materials 662 
 663 
Figure S1. (A) Whole-mount in situ hybridization using DIG-labeled LNA probes 664 
(Exiqon) against miR-203 at early chick developmental stages. 665 
 666 
667 
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Figure S2: (A) Diagram of electroporation assay for gain-of-function 668 
experiments. pCAG-miR-203 does not have a fluorescent marker, for this 669 
reason, was co-electroporated with a fluorescent vector that express GFP 670 
downstream the CAG promoter. We injected the vectors in the right side of the 671 
embryos at stage 4. Following injection, embryos were electroporated and 672 
cultured until stage 9. (B) Electroporation of pCAG-203 vector (right side) 673 
successfully overexpress a mature miR-203 evidenced by in situ hybridization 674 
using LNA probes. (C) Schematic drawing of the miRNA dual-sensor vector 675 
(pSdmiR-203) containing two copies of complementary sequences to the 676 
mature miR-203. (D) Illustration of bilateral electroporation assay to evaluate if 677 
pCAG-203 express a functional miR-203. (E) Co-electroporation pSdmiR-203 678 
and the empty pCAG vector (left side) caused that most of the cells are yellow 679 
because of the expression of both green and red reporters. Whereas, co-680 
electroporation pSdmiR-203 and pCAG-203 vector (right side) caused that most 681 
of the cells are only red, because of the strong repression of the green reporter. 682 
pCAG, Chick β-actin promoter; d4EGFPN nuclear-localized destabilized EGFP 683 
with a half-life of 4 h; mRFPN, nuclear-localized monomeric red fluorescent 684 
protein. 685 
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Supplementary table 1: In silico analyzes of conserved and poorly conserved 688 
microRNA-binding sites on Snail2 and Phf12 3’UTRs (TargetScan), their known 689 
functions, demonstrated targets, and chick expression (GEISHA).   690 
GEISHA microRNAs expression in chick development 691 
http://geisha.arizona.edu/geisha/quick_search.jsp?table=mir 692 
miR-1 (Wei et al., 2014, Wystub et al., 2013, Heidersbach et al., 2013) 693 
miR-19 (Olive et al., 2009, Mavrakis et al., 2010, Liu et al., 2011) 694 
miR32-5p/92-3p/367 (Zhu et al., 2013a, Zhu et al., 2015, Sharifi and Salehi, 695 
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miR-33-5p (Mi et al., 2016, Wang et al., 2016) 697 
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Egawa et al., 2016) 699 
miR-142 (Lu et al., 2013, Borges et al., 2016, Sonda et al., 2013, Dickman et 700 
al., 2017) 701 
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Benaich et al., 2014) 706 
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Supplementary table 2: Results obtained with the Jaspar 2018 (http://jaspar.genereg.net/) 1074 
for SNAIL2 binding site in the tentative promoter of miR-203. High binding sites (>9) are 1075 
mapped in figure 2A. We also show the sequence analyzed in Jaspar 2018. 1076 
 1077 
 1078 
 1079 
Supplementary table 3: Complete list of utilized primers, LNA probe, and morpholinos 1080 
 1081 
Gene/Direction Sequence 
LNA Probe 
dre-miR-203a(gga-miR-
203) CAAGTGGTCCTAAACATTTCAC 
RT-qPCR Primer Sequences 
stem-loop-gga-miR-203 GTCTCCTCTGGTGCAGGGTCCGAGGTATTCGCACCAGAGGAGACCAAGTG 
stem-loop-gga-miR-16 GTCTCCTCTGGTGCAGGGTCCGAGGTATTCGCACCAGAGGAGACCAAGTG 
qPCR-gga-miR-203 Fwd CCGGCGTGAAATGTTTAGG 
qPCR-gga-miR-16 Fwd CGCCGCTAGCAGCACGTAAA 
qPCR-gga-miR-universal 
Rev GAGGTATTCGCACCAGAGGA 
qPCR-Snail2 Fwd GCCAAACTACAGCGAACTGG 
qPCR-Snail2 Rev CGGAGAGAGGTCATTGGGTA 
qPCR-Phf12-Fwd CTGAGGAACCCTTGCAGAAG 
qPCR-Phf12-Rev AGAGTCCCAAAGCGAAGTCA 
qPCR-HPRT1-Fwd TGGTGAAAGTGGCCAGTTTG 
qPCR-HPRT1-Rev TCATTGTAGTCGAGGGCGTATC 
Bisulfite Primer Sequences 
Proximal region 
P-miR-203 Fwd AGGTAGTTTGGAAAAATTGGTTT 
P-miR_203 Rev CTCCTTTAAAAACATTACAACCC 
PN-miR-203 Fwd AAGTTTTGTTGTTGTTGTTATTTT 
PN-miR-203 Rev TAAACTATTAAAAACCACTACACCA 
Distal region 
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D-miR-203 Fwd TTTATATTTGTTGAGGGGAAGG 
D-miR-203 Rev TTTCCAAACTACCTTCTCCCTA 
DN-miR-203 Fwd TTGTGTGAGGTTGGTAGTTAGG 
DN-miR-203 Rev ATCATCATCATCTAAAACAACCC 
pCAG-miR-203 cloning 
XhoI-gga-miR-203 Fwd AAACTCGAGCTCCGAGCTGAGAAGAATGG 
EcoRV-gga-miR-203 Rev AAAGATATCCGCGCACTACAAGCCTATTT 
Sponge cloning 
miR-203 sponge Fwd 
gtcccCAAGTGGTCCGCTCATTTCACgaatatCAAGTGGTCCGCTCATTTCACg
g 
miR-203 sponge Rev 
gacccGTGAAATGAGCGGACCACTTGatattcGTGAAATGAGCGGACCACTT
Ggg 
Scramble sponge Fwd 
gtcccATCTAGCTGATCTAATCGAACaatatATCTAGCTGATCTAATCGAACgg 
Scramble sponge Rev 
gacccGTTCGATTAGATCAGCTAGATatattGTTCGATTAGATCAGCTAGATgg 
pUTRs cloning 
Snail2-3'UTR Fwd ACGCGTGTCATGCAGTCAATGTTTAC 
Snail2-3'UTR Rev GCTAGCTTTCACTTCACGCTTTCTTC 
mutSnail2-3'UTR SITIO A 
Fwd ATGCATGAGACCCGCAGTAGATCTAAACG 
mutSnail2-3'UTR SITIO A 
Rev GCGGGTCTCATGCATGGCATCTTTCCCC 
mutSnail2-3'UTR SITIO B 
Fwd CAAGCGACCCGCACCAAAGAAACAGTATTTTAATGG 
mutSnail2-3'UTR SITIO B 
Rev GGTGCGGGTCGCTTGGCAGGAATGTATTAGTAAC 
Phf12-3'UTR SanDI Fwd AAAGGGTCCCGAATTTGGAGGAAGGGAGCT 
Phf12-3'UTR Rev GCTAGCTACAGTGGAGCTAGCTGGCC 
mutPhf12-3'UTR Rev AAAACGCGTGCTGCTCTCGCTGCAGTTTTCCTTTTAAAAGCGGGTCTATAG 
    
Morpholinos Sequences 
DNMT3A MO TGGGTGTGTCACTGCTTTCCACCAT 
DNMT3B MO CGAGGCTCGTTACCATGCTCATCGC 
SNAIL2 MO TCTTGACCAG GAAGGAGC 
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